Neurol India Home 
 

Year : 1999  |  Volume : 47  |  Issue : 3  |  Page : 206--9

Botulinum toxin treatment of hemifacial spasm and blepharospasm : objective response evaluation.

A Thussu, CR Barman, S Prabhakar 
 Department of Neurology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160 012, India., India

Correspondence Address:
A Thussu
Department of Neurology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160 012, India.
India

Twenty seven patients with hemifacial spasm (HFS) and sixteen patients with blepharospasm (BS) having mean Jankovic disability rating scale score of 2.56+0.58 SD and 2.81+0.54 SD, respectively, were treated with botulinum toxin A (BTX-A) injections. The total number of injection sessions were ninety one with relief response in 98.91%. The mean improvement in function scale score was 3.78+0.64 SD and 3.29+1.07 SD respectively, in HFS and BS groups. The clinical benefit induced by botulinum toxin lasted for a mean of 4.46+3.11 SD (range 2 to 13) months in HFS group and 2.66+1.37 SD (range 1 to 6) months, in BS groups. Transient ptosis was seen in 4.39% of total ninety one injection sessions. These findings show that local botulinum toxin treatment provides effective, safe and long lasting relief of spasms.


How to cite this article:
Thussu A, Barman C R, Prabhakar S. Botulinum toxin treatment of hemifacial spasm and blepharospasm : objective response evaluation. Neurol India 1999;47:206-9


How to cite this URL:
Thussu A, Barman C R, Prabhakar S. Botulinum toxin treatment of hemifacial spasm and blepharospasm : objective response evaluation. Neurol India [serial online] 1999 [cited 2021 Oct 16 ];47:206-9
Available from: https://www.neurologyindia.com/article.asp?issn=0028-3886;year=1999;volume=47;issue=3;spage=206;epage=9;aulast=Thussu;type=0